https://interactiveprotocols.com/index.php/ccpr/issue/feedCurrent Clinical & Pharmaceutical Research2023-08-01T05:21:09+00:00Dr. Lutchmee Jhummuneditor@vcareclinic.infoOpen Journal Systems<p><strong>ISSN:2961-0753</strong> / Current Clinical and Pharmaceutical Research is peer reviewed open access Journal publish 4 issues yearly (Quarterly) . The journal publishes original research in the field of Clinical and Pharmaceutical research . The Journal has been designed to cover all the fields of research, which has any correlation and impact on Clinical Research and Pharmaceutical Research (Pharmacognosy, Natural Product, Pharmaceutics, Novel Drug Delivery, Pharmaceutical Technology, Biopharmaceutics, Pharmacokinetics,</p>https://interactiveprotocols.com/index.php/ccpr/article/view/16The Covid-19: An agent in Bioterrorism 2023-08-01T05:21:09+00:00Priyanka Rathorerathorepriyanka0211@gmail.com<p>Bioterrorism is a form of terrorism where there is intentional release of biological agent<br>(bacteria, virus, fungi or other germs) to cause harm, illness or death of people,<br>livestock and crops. It is an unlawful use of microorganisms to inflict various forms of<br>harm/harmful incidence or injuries in humans, whole population and environment.<br>There are reasons why this COVID-19 global pandemic appears to represent a<br>deliberate act of Bioterrorism. This is occurring at a critical time in the worldwide<br>especially in times of US presidential election cycle. It appears to be worse in males<br>which has implications for military which might be seen as a biological weapon. This<br>has created a market whiplash the large pullback in markets. COVID-19 represents a<br>tremendous opportunity for investment and wealth redistribution like Swine flu<br>pandemic in 2008-2009 when fortunes were made during that recovery.</p>2023-07-15T00:00:00+00:00Copyright (c) 2023